ACPU Announces Keynote Speakers for 2014 Annual Meeting

Share Article

The Association of Clinical Pharmacology Units (ACPU) announces that Congresswoman Diana DeGette, representing the 1st district of Colorado, and Rob DiCicco, Vice President, Clinical Pharmacology Sciences and Study Operations at GlaxoSmithKline, will Keynote the ACPU 2014 Annual Meeting in Denver Colorado.

Representative DeGette will keynote ACPU’s annual meeting this year.

The Association of Clinical Pharmacology Units (ACPU), the home for the Phase I/Clinical Pharmacology clinical research community, has announced that Congresswoman Diana DeGette, representing the 1st district of Colorado, will be the keynote speaker for their 2014 Annual Meeting in Denver Colorado, along with Rob DiCicco, Vice President, Clinical Pharmacology Sciences and Study Operations at GlaxoSmithKine.    

The ACPU Annual Meeting will take place at the Historical Brown Palace, in downtown Denver on October 15-17, 2014.

“We are thrilled for Representative DeGette to open as our keynote speaker for ACPU’s annual meeting this year,” said Angela Baker, ACPU President, “Congresswoman DeGette is a bi-partisan leader in the 21st Century Cures initiative that aims to accelerate the pace of cures and medical breakthroughs in the United States.”

Baker also announced the release of the final annual meeting program, including educational and networking events, saying, “This year we have a truly outstanding program, focused on leveraging partnerships and collaboration to address complexity in today’s early-phase clinical research trials.” The program and registration details are available at ACPU.net.

The opportunity to tour a local Clinical Pharmacology Unit is always a big draw at ACPU’s annual meeting. DaVita Clinical Research is hosting the 2014 meeting and will offer tours of their state-of-the-art Phase I research clinic in Lakewood, Colorado on Wednesday afternoon, October 15.

ACPU members are a community of Clinical Pharmacology Units (CPUs), their staff, and CPU support professionals. While other associations address the science of early phase/clinical pharmacology clinical trials, ACPU is the only organization which provides support for CPUs and staff to meet the significant operational challenges of early phase study conduct. For more information, visit http://www.acpu.net.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

John Rosenblum
ACPU

Visit website